Potential NTCP reductions for high-risk prostate cancer patients by MR-guided adaptive radiotherapy

R.L. Christiansen; L. Dysager; C.R. Hansen; T. Schytte; A.S. Bertelsen; H.R. Jensen; F. Mahmood; C.J. Nyborg; S. Hansen; S.N. Agergaard; O. Hansen; C. Brink; U. Bernchou

doi:10.1016/S0167-8140(22)03653-2

Potential NTCP reductions for high-risk prostate cancer patients by MR-guided adaptive radiotherapy

R.L. Christiansen, L. Dysager, C.R. Hansen, T. Schytte, A.S. Bertelsen, H.R. Jensen, F. Mahmood, C.J. Nyborg, S. Hansen, S.N. Agergaard, O. Hansen, C. Brink, U. Bernchou

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	PO-1689
Journal	Radiotherapy and Oncology
Volume	170
Issue number	Suppl. 1
Pages (from-to)	S1488-S1489
ISSN	0167-8140
DOIs	https://doi.org/10.1016/S0167-8140(22)03653-2
Publication status	Published - 2022
Event	European Society for Therapeutic Radiology and Oncology - København, Denmark Duration: 6. May 2022 → 10. May 2022

Conference

Conference	European Society for Therapeutic Radiology and Oncology
Country/Territory	Denmark
City	København
Period	06/05/2022 → 10/05/2022

Documents & Links

10.1016/S0167-8140(22)03653-2

SDU Link

Check access to the material in SDU Library's search engine

Cite this

Christiansen, R. L., Dysager, L., Hansen, C. R., Schytte, T., Bertelsen, A. S., Jensen, H. R., Mahmood, F., Nyborg, C. J., Hansen, S., Agergaard, S. N., Hansen, O., Brink, C., & Bernchou, U. (2022). Potential NTCP reductions for high-risk prostate cancer patients by MR-guided adaptive radiotherapy. Radiotherapy and Oncology, 170(Suppl. 1), S1488-S1489. Article PO-1689. https://doi.org/10.1016/S0167-8140(22)03653-2

@article{fb919dafb0c74d5698240837c2227349,

title = "Potential NTCP reductions for high-risk prostate cancer patients by MR-guided adaptive radiotherapy",

author = "R.L. Christiansen and L. Dysager and C.R. Hansen and T. Schytte and A.S. Bertelsen and H.R. Jensen and F. Mahmood and C.J. Nyborg and S. Hansen and S.N. Agergaard and O. Hansen and C. Brink and U. Bernchou",

year = "2022",

doi = "10.1016/S0167-8140(22)03653-2",

language = "English",

volume = "170",

pages = "S1488--S1489",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier",

number = "Suppl. 1",

note = "European Society for Therapeutic Radiology and Oncology ; Conference date: 06-05-2022 Through 10-05-2022",

}

Christiansen, RL, Dysager, L, Hansen, CR , Schytte, T, Bertelsen, AS, Jensen, HR, Mahmood, F , Nyborg, CJ , Hansen, S, Agergaard, SN, Hansen, O, Brink, C & Bernchou, U 2022, 'Potential NTCP reductions for high-risk prostate cancer patients by MR-guided adaptive radiotherapy', Radiotherapy and Oncology, vol. 170, no. Suppl. 1, PO-1689, pp. S1488-S1489. https://doi.org/10.1016/S0167-8140(22)03653-2

TY - ABST

T1 - Potential NTCP reductions for high-risk prostate cancer patients by MR-guided adaptive radiotherapy

AU - Christiansen, R.L.

AU - Dysager, L.

AU - Hansen, C.R.

AU - Schytte, T.

AU - Bertelsen, A.S.

AU - Jensen, H.R.

AU - Mahmood, F.

AU - Nyborg, C.J.

AU - Hansen, S.

AU - Agergaard, S.N.

AU - Hansen, O.

AU - Brink, C.

AU - Bernchou, U.

PY - 2022

Y1 - 2022

U2 - 10.1016/S0167-8140(22)03653-2

DO - 10.1016/S0167-8140(22)03653-2

M3 - Conference abstract in journal

SN - 0167-8140

VL - 170

SP - S1488-S1489

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

IS - Suppl. 1

M1 - PO-1689

T2 - European Society for Therapeutic Radiology and Oncology

Y2 - 6 May 2022 through 10 May 2022

ER -